HEALTH● LOWSep 8 · Sep 8, 2026, 5:00 AM
Cholesterol drug setback casts doubt over multibillion-dollar race
CNBC · global
Novartis’ failure raises the stakes for Amgen and Eli Lilly in the race to turn lower Lp(a) levels into fewer heart attacks and strokes.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH29m agoNo Confirmed Case Of Diphtheria In Enugu — CommissionerChannels TVHEALTH44m agoWhat I learned from my stroke at 26BBC AfriqueHEALTH46m agoFG, Katsina Boosts Emergency Healthcare With 18 Ambulances, Upgraded General HospitalChannels TVHEALTH55m agoNicole Kidman's 59-year-old breakfast: matcha tea, puffed rice, red fruits, and almond milkClarín